metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Baiona’s Consensus Statement for Fecal Incontinence. Spanish Association of Co...
Journal Information
Visits
125
Vol. 102. Issue 3.
Pages 158-173 (March 2024)
Special article
Full text access
Baiona’s Consensus Statement for Fecal Incontinence. Spanish Association of Coloproctology
Consenso Baiona sobre Incontinencia Fecal: Asociación Española de Coloproctología
Visits
125
Javier Cerdán Miguela,
Corresponding author
fjcerdan@hotmail.com

Corresponding author.
, Antonio Arroyo Sebastiánb, Antonio Codina Cazadorc, Fernando de la Portilla de Juand, Mario de Miguel Velascoe, Alberto de San Ildefonso Pereiraf, Fernando Jiménez Escovarg, Franco Marinelloh, Mónica Millán Scheidingi, Arantxa Muñoz Duyosj, Mario Ortega Lópezk, José Vicente Roig Vilal, Gervasio Salgado Mijaielm
a Unidad de Coloproctología, Hospital Viamed Santa Elena, Madrid, Spain
b Servicio de Cirugía General y Aparato Digestivo, Unidad de Coloproctología, Hospital General Universitario de Elche, Elche, Alicante, Spain
c Servicio de Cirugía General y Digestiva, Unidad de Coloproctología, Hospital Universitario de Girona, Girona, Spain
d Servicio de Cirugía General, Unidad de Coloproctología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
e Unidad de Coloproctología, Hospital Virgen del Camino, Pamplona, Spain
f Unidad de Coloproctología, Servicio de Cirugía General, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain
g Unidad de Coloproctología, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain
h Unidad de Cirugía Colorrectal, Hospital Universitario Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
i Unidad de Coloproctología, Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario y Politécnico la Fe, Valencia, Spain
j Unidad de Coloproctología, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona, Spain
k Unidad de Coloproctología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
l Unidad de Coloproctología, Hospital Vithas 9 de Octubre, Valencia, Spain
m Unidad de Coloproctología, Hospital Santa Elena, Marbella, Málaga, Spain
Ver más
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Levels of evidence according to the criteria of the Oxford Centre for Evidence-Based Medicine (CEBM).
Tables
Table 2. Grades of recommendation (CEBM).
Tables
Show moreShow less
Figures (1)
Abstract

Faecal incontinence (FI) is a major health problem, both for individuals and for health systems. It is obvious that, for all these reasons, there is widespread concern for healing it or, at least, reducing as far as possible its numerous undesirable effects, in addition to the high costs it entails.

There are different criteria for the diagnostic tests to be carried out and the same applies to the most appropriate treatment, among the numerous options that have proliferated in recent years, not always based on rigorous scientific evidence.

For this reason, the Spanish Association of Coloproctology (AECP) proposed to draw up a consensus to serve as a guide for all health professionals interested in the problem, aware, however, that the therapeutic decision must be taken on an individual basis: patient characteristics/experience of the care team.

For its development it was adopted the Nominal Group Technique methodology. The Levels of Evidence and Grades of Recommendation were established according to the criteria of the Oxford Centre for Evidence-Based Medicine. In addition, expert recommendations were added briefly to each of the items analysed.

Keywords:
Fecal incontinence
Sphincteroplasty
Biofeedback
Sacral nerve stimulation
Posterior tibial nerve stimulation
Transanal irrigation
Resumen

La incontinencia fecal (IF) constituye un importante problema sanitario, tanto a nivel individual como para los diferentes sistemas de salud, lo que origina una preocupación generalizada para su resolución o, al menos, disminuir en lo posible los numerosos efectos indeseables que provoca, al margen del elevado gasto que ocasiona.

Existen diferentes criterios relacionados con las pruebas diagnósticas a realizar, y lo mismo acontece con relación al tratamiento más adecuado, dentro de las numerosas opciones que han proliferado durante los últimos años, no siempre basadas en una rigurosa evidencia científica.

Por dicho motivo, desde la Asociación Española de Coloproctología (AECP) nos propusimos elaborar un Consenso que sirviese de orientación a todos los profesionales sanitarios interesados en el problema, conscientes, no obstante, de que la decisión terapéutica debe tomarse de manera individualizada: características del paciente/experiencia del terapeuta.

Para su elaboración optamos por la técnica de grupo nominal. Los niveles de evidencia y los grados de recomendación se establecieron de acuerdo a los criterios del Oxford Centre for Evidence-Based Medicine. Por otra parte, en cada uno de los ítems analizados se añadieron, de forma breve, recomendaciones de los expertos.

Palabras clave:
Incontinencia fecal
Esfinteroplastia
Biofeedback
Neuromodulación de raíces sacras
Neuromodulación tibial posterior
Irrigación transanal
Graphical abstract
Full Text
Introduction

Fecal incontinence (FI) is the loss of the ability to retain or to voluntarily eliminate and discriminate rectal effluents. Factors involved in defecation are neurological, myogenic, sensory, hormonal and anatomical. In addition to these factors are a large number of variables that participate in the complex interaction of continence, such as: stool consistency, reservoir capacity, rectal compliance, rectal sensation, and effective sphincter pressures at rest and during contraction.

The most common etiology (at least in a surgical consultation) is obstetric trauma, although other factors may be involved. The most important include anal surgery, anal and perineal trauma, radiation therapy, chronic straining during defecation, neurological problems, psychosis, side effects of medication, and food intolerance.

Apart from the FI itself, 3 transcendental concepts should be differentiated:

  • a)

    Passive incontinence: incontinence accident of a complete or near-complete abundant stool, which occurs with no prior warning or desire to defecate, typical of neurological disorders and severe pelvic organ prolapse.

  • b)

    Soiling: emission of a small amount of feces or mucus through the anus that is continuous, occasional, or post-defecatory, which can cause anal and perianal margin irritation.

  • c)

    Fecal urgency: sudden desire to defecate which the patient is unable to defer.

The exact incidence and prevalence of FI is difficult to determine, ranging from 2% to 20.7%. This incidence increases in patients admitted to nursing homes and is very frequently associated with urinary incontinence.1,2 It not only has a transcendental psychosocial impact, but it also entails a high financial cost for healthcare systems and individuals.3,4

The diagnosis and treatment of FI are complicated by its multifactorial etiology and multiple conditions involved. Currently, there is no unanimity when it comes to recommending the most effective diagnostic methods or applying the most appropriate therapeutic measures for each case, which is why discrepancies are frequently found in the literature and even among different clinical guidelines.5

Methods

Under the auspices of the Spanish Association of Coloproctology and during the 27th International Coloproctology Conference held in Baiona (Spain) in 2019, a decision was made to develop a consensus document on fecal incontinence, with the purpose to aid in the diagnosis and treatment of this problematic pathology, directed at all surgeons and healthcare workers concerned about the issue.

Among the different modalities used to develop a consensus document in medicine, the “Nominal Group Technique” was chosen.6,7

The consensus group was comprised of 12 experts, all with extensive experience and interest in FI, and one General Coordinator. A roundtable discussion was held to assess all the problems and discrepancies regarding the diagnosis and treatment of FI.

Six working groups were created with 4 participants each; thus, each expert participated in 2 different groups that analyzed differing topics. A coordinator was nominated for each group, who distributed the topics among the participants. The experts made their evaluations based on their experience as well as an analysis of the literature by means of a structured qualitative review of sources identified by the search engines usually used in biomedical research: PubMed, MEDLINE, EMBASE and Cochrane Library, both in Spanish and English, until March 2022. The search terms were: “anal incontinence”, “fecal incontinence”, “sphincteroplasty”, “sacral nerve stimulation”, “posterior tibial nerve stimulation”, “bulking agents”, “dietary treatment”, and “artificial anal sphincter”.

Clinical experimental articles in Spanish and English were included in order to evaluate and present possible future alternatives. The Levels of Evidence and Grades of Recommendation were established following the criteria of the Oxford Center for Evidence-Based Medicine8 (Tables 1 and 2).

Table 1.

Levels of evidence according to the criteria of the Oxford Centre for Evidence-Based Medicine (CEBM).

Level  Type of study 
1a  Systematic review of randomized clinical trials (with homogeneity) 
1b  Randomized clinical trial with a narrow confidence interval 
1c  Clinical practice (all or none) 
2a  Systematic review of cohort studies (with homogeneity) 
2b  Cohort studies of randomized clinical trial with low quality 
2c  Outcomes research; ecological studies 
3a  Systematic review of case-control studies (with homogeneity) 
3b  Case-control study 
Series of cases or cohort studies and low-quality case-control studies 
Expert opinion with no explicit critical assessment or based on physiology 
Table 2.

Grades of recommendation (CEBM).

Grade  Level of evidence 
Level 1 studies 
Leve 2–3 studies, or extrapolated Level 1 studies 
Level 4 studies, or extrapolated Level 2–3 studies 
Level 5 studies, or inconclusive studies of any level 

Once the corresponding items were prepared by each expert, they were assessed by the Group Coordinator and the General Coordinator, who included comments that they considered appropriate. After this second proposal, the topics were sent to all the members of the group for another assessment. After the final analysis in each Group, the study and proposals were sent electronically to the entire group of experts who again made the recommendations they deemed pertinent.

Lastly, the manuscript and its main recommendations were presented at the 28th International Coloproctology Conference, held in Baiona in 2022.

After this rigorous preparation, the Baiona Consensus Statement on Fecal Incontinence document was drawn up, under the auspices of the AECP.

Clinical history — physical examination

Considering the possible multifactorial etiology, all antecedents that could alter one or more should be analyzed in the clinical history. The medical history must include the following factors:

Symptoms of incontinence

  • Time of evolution

  • Correlation with changes in intestinal habit

  • Characteristics of incontinence (soiling, passive, defecatory urgency, mixed)

  • Intensity of symptoms (severity of incontinence)

  • Accompanying symptoms (mucorrhea, bleeding)

  • Finally, questions aimed at clarifying the type of involvement, defining the following factors:

    • o

      QUALITY: lack of control refers to gases, liquid stools or solid stools?

    • o

      FREQUENCY: leaks are daily, weekly, monthly, or sporadic?

    • o

      DEGREE OF SOCIAL IMPACT: exact impact for each person?

All of these parameters are quantified using a calendar or evacuation diary that patients complete for three weeks, where all events related to incontinence are recorded in detail.9–11

Background — identification of risk factors

  • Age

  • Hygienic-dietary habits (tobacco, amount of fiber in the diet, body mass index, limited physical activity)

  • Medical history (neurodegenerative, metabolic, digestive pathology)

  • Previous medication, or changes

  • Associated urinary incontinence

  • Surgical history (previous anorectal surgery)

  • Obstetric–gynecological history (childbirth, laborious births, traumatic births, hysterectomy, genital prolapse)

  • Trauma history (pelvic–perineal trauma)9,11–13

Physical examination

A detailed physical examination is essential for the correct evaluation of patients with FI, which will include:

Inspection of the perineal area (rest and contraction) to evaluate scars, asymmetries, suppurative pathology, prolapses, perineal descent and dermatitis or excoriations in the perianal skin, as well as sensitivity in the perineal skin.

The digital rectal examination provides subjective, but very reliable, evaluation of rest and effort pressures as well as muscle coordination, with expulsion or retention maneuvers. Furthermore, it rules out pathologies, such as rectal tumors or stenosis and sometimes the presence of fecal impaction.14

Basic instrumentation (anoscopy, proctoscopy) can be useful as a complement to rectal examination to identify other anal pathologies.3,15

Expert recommendations

To study fecal incontinence, a detailed and directed anamnesis is essential, as well as a physical examination that includes inspection and examination, both digital and instrumental.

Level of evidence 1c; grade of recommendation A.

Scoring instruments that evaluate the severity of fecal incontinence

Measuring FI is challenging. To evaluate the severity of this symptom, several scoring systems have been developed to define the subjective perception of the patient, evaluate the treatments for their scientific dissemination in a homogeneous manner.

Scoring instruments can be either simple scales or grading scales. On simple scales, patients define their degree of fecal continence ranging from 0 to 10.

Grading scales include measuring fecal loss in type and frequency, the use of coping mechanisms, and the impact on lifestyle.

In our setting, the most used scales are the Cleveland Clinic or Jorge–Wexner scores16 and the St Mark’s or Vaizey incontinence scales,17 which are easy to conduct and interpret.

None of these scales have been validated, nor do they assess soiling. This has led certain studies to analyze the limited correlation between the assessment of the scores and the subjective perception reflected by the visual analogue scale.18

In the literature, there is no consensus on which is the best instrument to assess the severity of fecal incontinence, but these should be used to identify more severe symptoms that may initially require more aggressive treatment. By homogenizing the treatments established, results could be compared between studies, populations and institutions.

Scoring instruments to evaluate the quality of life in fecal incontinence

The impact of fecal incontinence on quality of life is a vital point in the management of these patients. Quality-of-life assessment scales are divided into generic and specific types. The most widely used generic scale is the SF-36 (Medical Outcomes Survey Short-Form),19 and the most widespread specific instrument (validated in Spanish) is the FIQL scale (Fecal Incontinence Quality-of-Life Scale).20

Expert recommendation

In the medical assessment of fecal incontinence and for scientific research purposes, specific severity and quality-of-life scales should be used in these patients, even though there are no studies that support their routine use.

Level of evidence 5; grade of recommendation D.

Diagnostic tests in fecal incontinenceEndoanal ultrasound

This is the main test used to study fecal incontinence, since objective, higher-quality images of the anal sphincters can be obtained compared to other methods. In most studies, its sensitivity and specificity for the detection of sphincter defects are in the range of 83%–100%.21,22

3D ultrasound does not provide much more information than 2D.23 The Starck score can be useful in the evaluation of these patients, especially in the presence of obstetric damage.24

Transvaginal and transperineal ultrasound

These can be useful in the event that the endoanal probe cannot be used.25

Magnetic resonance imaging

Especially useful to detect external anal sphincter (EAS) atrophy26,27

Defecography and MRI defecography

Its use must be individualized and used on an exceptional basis.28

Anal manometry and sensitivity tests

Conventional anal manometry, with electronic or pneumatic perfusion, is used to measure anal canal pressures and rectal sensitivity. As a minimum, the following parameters must be collected: maximum resting pressure, maximum contraction pressure, length of the anal canal (at rest and contraction), point of maximum pressure, minimum and maximum tolerated sensitivity, and finally the rectoanal inhibitory reflex.29,30

Neurophysiological tests

These are not frequently recommended.

In the future, we must consider the role that the determination of evoked potentials will play in testing the cerebral cortex. Likewise, the determination of the conduction of peripheral nerves, especially the posterior tibial nerve (in its sural sensory and motor branches) should be considered to assess therapy with peripheral neurostimulation.31,32

Anoscopy and rectoscopy

These are used in order to rule out other coexisting processes, especially in patients with tenesmus.33 In select cases, colonoscopy is used.

Expert recommendations

1) Anal ultrasound is mandatory in the diagnosis of patients with fecal incontinence, especially to detect structural anomalies of the sphincter complex.

Level of evidence 3b; grade of recommendation B.

2) MRI can be useful in certain circumstances, especially to determine sphincter atrophy.

Level of evidence 3b; grade of recommendation C.

3) Both defecography and MRI defecography have limited value in the diagnosis of FI, as they only have a certain role in patients presenting prolapses of other pelvic organs.

Level of evidence 3b; grade of recommendation C.

4) Colonoscopy can be useful for diseases that may exacerbate FI (diarrhea, etc.), but the related data available are very limited.

Level of evidence 5; grade of recommendation D.

5) Anorectal manometry can be useful in the diagnosis of FI, but never alone.

Level of evidence 3b; grade of recommendation C.

6) Although manometry can be useful to guide treatment alternatives, it is currently difficult to know its true impact.

Level of evidence 3b; grade of recommendation B.

7) High-resolution manometry is a new and promising technique; however, there are currently not enough studies to support its recommendation.

Level of evidence 4; grade of recommendation C.

8) Latency of the Motor Nerve should not be used in the diagnosis of fecal incontinence as a predictor of a successful sphincteroplasty.

Level of evidence 4; grade of recommendation C.

9) Needle electromyography (EMG) is the only technique to identify neurological damage.

Level of evidence 2a; grade of recommendation B.

Conservative treatment

Different conservative measures can provide satisfactory results that avoid surgical treatment. These include:

Diet

Dietary modifications can provide satisfactory results, with the aim of improving the frequency and consistency of bowel movements.34,35

Expert recommendations

In patients with fecal incontinence, it is advisable to record daily eating habits in a diary in order to personalize dietary recommendations.

Level of evidence 3b. Grade of recommendation C.

Fiber

Fiber improves stool consistency by absorbing excess intraluminal water. It is indicated in cases of fecal incontinence associated with diarrhea and liquid stools or stools of reduced consistency.36,37

Expert recommendations

Psyllium may be indicated in patients with fecal incontinence associated with stools of a soft or liquid consistency. Said fiber must be administered with a small amount of water so that the astringent effect is achieved.

Level of evidence 3b; grade of recommendation C

Transanal irrigation

This is based on emptying the colon of the maximum amount of fecal matter, used regularly. The published results are variable, the dropout rate is high, and adverse effects are not negligible.38,39 However, it can be recommended in select cases.40

Expert recommendations

Transanal irrigation may be recommended as a second line of treatment in patients with defecatory dysfunction of neurological causes or with low anterior resection syndrome.

Level of evidence 2b; grade of recommendation B.

Pharmacological treatment

Different drugs have been used with the aim of achieving pseudo-constipation to avoid soft or liquid stools, or with the purpose of increasing the resting pressure of the internal sphincter.41–44 The evidence is very limited, with multiple biases, which has led to its use being exceptional.

Expert recommendations

Antidiarrheal drugs like loperamide may be indicated in patients with fecal incontinence associated with stools of a soft or liquid consistency.

Level of evidence 2a; grade of recommendation B.

Experience is limited with the use of topical drugs that increase anal pressure or with the administration of antidepressants.

Level of evidence 4; grade of recommendation D.

Biofeedback

The objective of biofeedback is to strengthen the pelvic muscles, re-educate rectal sensitivity and coordinate the pelvic muscles with defecation.45–47 In addition, it can be a satisfactory complementary treatment after sphincteroplasty.48,49

Expert recommendations

Biofeedback may be useful in the treatment of FI in combination with other conservative treatment modalities.

Level of evidence 2a; grade of recommendation B.

Pelvic floor rehabilitation

This entails performing short or long repeated contractions of the external anal sphincter and the puborectalis, while keeping the abdominal muscles relaxed. Better results have been reported when it is used in combination with biofeedback.50,51

Expert recommendations

Pelvic floor rehabilitation is a treatment option for fecal incontinence as part of conservative treatment, which is recommended based on its low cost, low morbidity and some evidence of effectiveness. Patients with little or no sphincter contractility capacity should be excluded. Its use is recommended in association with biofeedback.

Level of evidence 3b, grade of recommendation B.

Electrostimulation

Electrostimulation consists of the utilization of anal probes or electrodes placed in the perineum. There is no evidence on possible benefits.52–54

Expert recommendations

Although there is little evidence, it seems that electrostimulation at high frequencies can improve the effectiveness of biofeedback.

Level of evidence 4; grade of recommendation D.

Palliative measuresAnovaginal mechanical devices

These are passive obstruction barriers that block the flow of feces in the rectum to help prevent fecal incontinence. Data on their effectiveness are limited.55–59

Expert recommendations

There is no evidence to indicate the use of anal plugs in fecal incontinence, although they may be recommended in select patients, with warnings about possible intolerance.

Level of evidence 4; grade of recommendation D.

The evidence for the use of mechanical vaginal devices for the treatment of fecal incontinence is limited, but they may be a good alternative within conservative treatments.

Level of evidence 4. Degree of recommendation D.

Surgical treatmentSphincteroplasty. Other surgical optionsIndications

External anal sphincter (EAS) repair is indicated in patients with symptoms of fecal incontinence, with a limited defect and sufficient residual muscle mass. Its objective is to restore the anatomical barrier necessary for continence. It can be indicated for any type of EAS lesion, but the patient selection criteria and results obtained are extremely variable.42,60–70

Surgical techniqueSphincteroplasty or suture of the external anal sphincter (EAS)

Sphincteroplasty is the most commonly performed technique to treat EAS defects secondary to obstetric, postoperative or accidental trauma.63,71–75

There is a growing tendency to use overlapping, even in primary repairs, although there are several technical variations depending on the habits and experience of each surgeon, with variable results.75–77

Expert recommendations

Sphincteroplasty is indicated in patients with severe fecal incontinence and observed sphincter injury of EAS or both sphincters between 30º and 180º of separation and that does not respond to conservative measures.

Level of evidence 2b; grade of recommendation B.

Overlapping the sphincter ends is superior to direct repair.

Level of evidence 3b; grade of recommendation B.

There are no differences between the use of resorbable suture material in the medium or long term.

Level of evidence 1b; grade of recommendation A.

Repair of both sphincters

There is enormous technical variability in relation to en bloc suturing of both sphincters or with individualized repair, and different series have reported non-homogeneous results.63,72,76–80 However, other authors have published satisfactory results with selective IAS suture, separated from the EAS.64,74,75 Given the variability of lesions in each case, rigorous randomization seems extremely difficult.

Expert recommendations

  • -

    Individualized repair of both sphincters improves results, so it should be performed whenever possible.

Level of evidence 2b; grade of recommendation B.

Isolated internal anal sphincter (IAS) repair

This has been attempted for defects with very symptomatic passive leaks secondary to fistulotomy or internal sphincterotomy. Although the results are usually not satisfactory, they can provide significant improvement to well-selected patients.81–83

Expert recommendations

  • -

    Repair of isolated IAS lesions can be performed, although with a low level of evidence.

Level of evidence 4; grade of recommendation C.

Association with levator plication

This has been used in association with sphincteroplasty, not only to treat sphincter defects,75,84 but also when there are none.85 However, there is no clear evidence of its use in cases of obstetric injuries, and it can lead to dyspareunia if the suture is tense.

Expert recommendations

  • -

    Levatorplasty should not be systematically associated with sphincteroplasty in obstetric injuries.

Level of evidence 5; grade of recommendation D.

Association with plastic surgery

In patients with a thin or absent perineal body, or even with a common anovaginal cloaca, plastic surgery procedures have been performed with good results, both in terms of improving continence and sexual function.86–88

Re-sphincteroplasty

When an anterior muscle defect persists or occurs over time, most series have obtained good results with re-sphincteroplasty. The failure of an initial repair does not exclude a new one.89–91

Expert recommendations

  • -

    It is feasible to perform a new sphincteroplasty when persistence or recurrence of the sphincter defect is proven.

Level of evidence 2b; grade of recommendation B.

Complications and prevention

Complications associated with sphincter repair occur in 15% of cases; they are usually mild and include infection and dehiscence of the surgical wound, abscess, bleeding, urinary retention, fecal impaction, dehiscence of the sphincter suture, pain and dyspareunia.92,93 Preventive measures are based on empirical treatments and general recommendations, such as the use of prophylactic antibiotics, partial or non-closure of the surgical wound, the use of antegrade colon preparation or preoperative cleansing enemas, and bladder catheterization, with no evidence of any benefits.

Protective stomas have been described in situations of risk of perianal sepsis and in extensive or complex sphincter defects, but they do not provide any benefit over a regular sphincteroplasty,94 nor does “chemical colostomy” seem to offer significant advantages.92

Expert recommendations

  • -

    A protective stoma is unnecessary to prevent complications after performing a sphincteroplasty.

Level of evidence 1b; grade of recommendation A.

Results

Sphincteroplasty improves fecal incontinence in 70%–90% of cases in the short term, but the assessment of success differs according to the studies,72,73,95 and they generally deteriorate over time.

However, other studies with long-term follow-up and rigorous controls demonstrate sustained improvement, confirming the prolonged effectiveness of the technique.61,66,75,96 Even so, patients should be informed about the possibility of progressive deterioration of sphincter function over time. No significant factors have been described for a poor prognosis.97

Expert recommendations

  • -

    Despite possible deterioration over time, sphincteroplasty provides functional results and improvement in quality of life that are satisfactory enough to be recommended.

Level of evidence 2b; grade of recommendation C.

Pelvic floor repairIndications

Indications include idiopathic (neuropathic) fecal incontinence and complex trauma to the external anal sphincter and puborectalis muscle.98,99 It has also been used in patients with descending perineum syndrome associated with decreased anal canal pressure and altered anorectal angle.100 Currently, it is an uncommon procedure.101,102

Expert recommendation

Pelvic floor repair can be performed in selected patients with idiopathic fecal incontinence and descending perineum syndrome, in whom significant weakness of the sphincter complex is observed, when other therapeutic options are not possible.

Level of evidence 4; grade of recommendation C.

Use of other muscles: muscle transposition

The objective is to create a neo-anal sphincter when direct repair of the sphincter complex is considered inappropriate, with the aim of passively increasing output resistance in patients with severe symptoms.

The most commonly used procedure is dynamic graciloplasty. The results are very heterogeneous, and the complication rate is high.103–107 The use of gluteoplasty is currently unusual.108,109

Expert recommendations

Graciloplasty and gluteoplasty, performed at medical centers with experience, can be considered in motivated patients as a final alternative prior to a colostomy.

Level of evidence 4; grade of recommendation D.

Sacral neuromodulationWhat is it?

Sacral neuromodulation (SNM) involves electrically stimulating a root of the sacral spinal nerve to modulate a neural pathway with the aim of treating defecatory dysfunction. After a test phase, if satisfactory, we move on to chronic or definitive stimulation. The surgical technique is highly reproducible and should be performed according to standards described by several expert committees.110–115

The mechanism of action of SNM is not yet completely known, but it is believed to act at the somatic motor, somatosensory, and autonomic levels, while mediating somatovisceral reflexes. It is seemingly not limited to the effector organ, as central and cortical effects have been demonstrated.116,117

Expert recommendations

A thorough and multangular evaluation of patients is necessary (defecation diary, subjective evaluation, scores, etc.), both at baseline and during the test phase, to avoid false positives or false negatives. The recommended cut-off point is 50% improvement in the evaluated parameters, although individualization is important.

Level of evidence 2b; grade of recommendation B.

Indications

In general terms, SNM is considered the second line of treatment for patients with moderate or severe FI who have not found improvement through conservative treatment.118–122 The short-term results in the literature demonstrate a reduction of more than 50% in incontinence episodes in 79% of patients implanted, maintaining an effectiveness of 83% after 3 years of follow-up.121,123–126

Expert recommendations

Sacral neuromodulation can be indicated as a second line of therapy in patients with fecal incontinence in whom conservative treatment fails. Multifactorial FI best responds to SNM.

Level of evidence 2b; grade of recommendation B.

Morbidity

The morbidity of SNM is low and mild, including pain related to stimulation or the implanted device and infection of the system. Patient followed-up should be lifelong because the incidence of minor events or transient relapses is considerable.127

Expert recommendations

It is recommended to closely monitor immune status and coagulation prior to performing SNM.

Level of evidence 3b. Grade of recommendation C.

There is no consistent evidence on how to act on the stimulation parameters when confronted with different incidents during follow-up, so it is recommended to rely on clinical experience.

Level of evidence 4; grade of recommendation D.

Efficacy by etiopathogenic subgroupsFecal incontinence in patients with injury to the external anal sphincter

The presence of a sphincter injury does not seem to influence the result of SNM.118,128,129

Expert recommendations

Neuromodulation may be indicated in selected patients with sphincter injury, preferably of long duration.

Level of evidence 2b; grade of recommendation B.

Neurological fecal incontinence

There is little evidence on its effects on neurological fecal incontinence.130,131

Expert recommendations

SNM offers a promising therapeutic option for patients with neurogenic incontinence refractory to other therapies.

Level of evidence 4; grade of recommendation C.

Incontinence in low anterior resection syndrome (LARS)

Although applied in small, heterogeneous samples, the results are encouraging.132–134

Expert recommendations

Although it is necessary to agree on a correct algorithm that considers the different variables related to LARS, SNM is indicated in these patients when conservative treatment has failed.

Level of evidence 4; grade of recommendation C.

Fecal incontinence in the context of chronic diarrhea

Various studies have shown improvement in the number of bowel movements after neuromodulation applied in different diarrheal conditions, although the evidence is scarce.135

Expert recommendations

Given the persistence of incontinence associated with diarrhea despite the application of conservative treatments, and after assessment by a digestive specialist, a neuromodulation trial phase may be indicated.

Level of evidence 4; grade of recommendation C.

Congenital fecal incontinence

There is little experience, and complex cases require thorough study and strict individualized technique.136–138

Expert recommendations

After meticulous study to confirm the existence of residual sphincter apparatus, SNM can be attempted in this type of patient.

Level of evidence 4; grade of recommendation C.

Posterior tibial nerve stimulation (PTNS)

The posterior tibial nerve contains sensory, motor, and autonomic fibers that originate from the roots of the S2–S4 sacral plexus. Its stimulation affects the sacral roots in retrograde related to visceral and muscular control of the pelvic floor, but the exact mechanism of action is unknown.139

Treatment can be percutaneous, with needle electrodes, or transcutaneous, with surface electrodes.140–142 Bilateral stimulation has been tested in limited studies.143,144

There are still numerous unknowns regarding indications, differences with SNM, need to maintain treatment, stimulation regimens and long-term results.145–151

Expert recommendations

1) PTNS offers an alternative to patients with less severe fecal incontinence, although its results are sometimes discreet.

Level of evidence 2b; grade of recommendation B.

2) The short- and medium-term results and its high acceptance by patients mean that PTNS can be used as a bridge therapy before offering SNS.

Level of evidence 2b; grade of recommendation B.

3) It can be performed both percutaneously and transcutaneously.

Level of evidence 2b; grade of recommendation B.

4) A standardized administration schedule cannot be recommended, although it seems that the most frequently used is 1–2 sessions per week for 3 months, followed by “booster” treatments with no clear schedule.

Level of evidence 2b; grade of recommendation B.

5) Offering PTNS when conservative treatment and/or biofeedback fail can reduce the need for SNS, or at least delay it.

Level of evidence 2b; grade of recommendation B.

Less common proceduresArtificial anal sphincter (AAS)

The high number of complications, with no viable solutions, has led to the disappearance of AAS.152–154

Magnetic anal sphincter (MAS)

The complication rate is high, and it has been taken of the market.

Bulking agents

The use of these products presents low complexity and morbidity rates.78,155,156 They are indicated in cases of internal sphincter injuries that cause soiling.78 There are no long-term results available.155–158

Expert recommendations

The use of bulking agents is a valid option for patients with soiling or other effects derived from an injury to the internal sphincter.

Level of evidence 3b; grade of recommendation C.

Injection of mesenchymal cells

This application is used in experimental research.159–161

Expert recommendations

Cell therapy presents promising results, but it is currently in the experimental field, so there is no evidence for its recommendation.

Radio frequency (SECCA)

Favorable results are limited, so its use is currently very limited.162–164

Expert recommendations

Although there is evidence of clinical improvement, poor long-term results mean that its use is currently very limited.

Level of evidence 3b; grade of recommendation C.

TOPAS (Trans Obturator Posterior Anal Sling)

Preliminary results are favorable,165–167 but its use is not approved.

Expert recommendations

Product not approved despite good preliminary results.

Malone anterograde continence enema (MACE)

Possible option in very select cases, but not free of complications.168–170

Expert recommendations

Malone anterograde continence enema is a valid therapeutic option in patients with incontinence and constipation, or with neurogenic bowel dysfunction, prior to the indication of a colostomy.

Level of evidence 3b; grade of recommendation C.

Acupuncture

Few studies, but good results171,172

Expert recommendations

In the absence of evidence, it cannot be recommended as a treatment.

Pyloric valve transposition

Anastomosis between the distal colon and the perianal skin, and the pylorus acts as a valve or “sphincter” mechanism.173–175

Expert recommendations

In the absence of clinical evidence, this alternative is in the experimental phase.

Colostomy

Although it is an aggressive option, it can radically improve the quality of life of patients when all therapeutic options have failed.176

Expert recommendations

No comparative studies have been published. Its use is recommended in consensus with the patient as the last therapeutic option.

In conclusion, FI is an important problem that significantly affects the quality of life of patients. There are numerous therapeutic options, which must be established only after thorough, meticulous assessment on an individualized basis.

Funding

The authors declare that they have received no funding.

Conflict of interests

The authors of the article do not have any commercial association that might pose a conflict of interest in relation to this article.

References
[1]
C. Cerdán, R. Santos, M. Vigara, C. Fernández, M. Ortega, J. Cerdán.
Prevalence of anal incontinence in a working population within a healthcare environment.
Scand J Gastroenterology, 52 (2017), pp. 1340-1347
[2]
C. Cerdán, M. Vigara, M. Ortega, J. Cerdán.
Faecal incontinence in older people: evaluation, treatment and new surgical techniques.
Am Geriatr Soc, 24 (2014), pp. 105-116
[3]
A.D. Markland, P.S. Googe, K.L. Burgio, D.T. Redden, H.E. Richter, P. Sawyer, et al.
Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study.
Am Geriatr Soc, 58 (2010), pp. 1341-1346
[4]
M.J. De Miguel, A. Margallo, M.A. Pérez, E. Sánchez, J.M. Cabasés, I. Alberdi, et al.
Impacto económico del tratamiento a largo plazo de la incontinencia fecal grave.
Cir Esp, 100 (2022), pp. 422-430
[5]
A. Muñoz-Duyos, L. Lagares-Tena, Y. Ribas, J.C. Baanante, A. Navarro-Luna.
Critical appraisal of international guidelines for the management of fecal incontinence in adults: is it possible to define what to do in diferent clinical scenarios?.
Tech Coloproctol, 26 (2022), pp. 1-17
[6]
S. Humphrey-Murto, L. Varpio, T.J. Wood, C. Gonsalves, L.-A. Ufholz, K. Mascioli, et al.
The use of the Delphi and other consensus group methods in medical education research: a review.
Acad Med, 92 (2017), pp. 1491-1498
[7]
J. Asua.
Entre el consenso y la evidencia científica.
Gac Sanit, 19 (2005), pp. 65-70
[8]
Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. «Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document)». Oxford Centre for Evidence-Based Medicine. Available from: http://www.cebm.net/index.aspx?o=5653.
[9]
J.Y. Wang, M.A. Abbas.
Current management of fecal incontinence.
Perm J, 17 (2013), pp. 65-73
[10]
K. Alavi, S. Chan, P. Wise, A.M. Kaiser, R. Sudan, L. Bordeianou.
Fecal incontinence: etiology, diagnosis and management.
J Gastrointest Surg, 19 (2015), pp. 1910-1921
[11]
E. Rey, R.S. Choung, C.D. Schleck, A. Zinsmeister, L. Talley.
Onset and risk factors for fecal incontinence in a US community.
Am J Gastroenterol, 105 (2010), pp. 412-419
[12]
M.K. Tonwsend, C.A. Matthews, W.E. Whitehead, F. Grodestein.
Risk factors for faecal incontinence in older women.
Am J Gastroenterol, 108 (2013), pp. 113-119
[13]
J.K. Johnson, S.W. Lindow, G.S. Duthie.
The prevalence of occult obstetric anal sphincter injury following childbirth-literature review.
J Matern Fetal Neonatal Med, 20 (2007), pp. 547-554
[14]
R.I. Hallan, D.E. Marzouk, D.J. Waldron, N.R. Womack, N.S. Williams.
Comparison of digital and manometric assessment of anal sphincter function.
Br J Surg, 76 (1989), pp. 973-975
[15]
A.C. Dobben, M.P. Terra, M. Deutekom, M.F. Gerhards, A. Bart Bijnen, R.J.F. Felt-Bersma, et al.
Anal inspection and digital rectal examination compared to anorectal physiology tests and endoanal ultrasonography in evaluating faecal incontinence.
Int J Colorectal Dis, 22 (2007), pp. 783-790
[16]
J.M. Jorge, S.D. Wexner.
Etiology and management of faecal incontinence.
Dis Colon Rectum, 36 (1993), pp. 77-97
[17]
C.J. Vaizey, E. Carapeti, J.A. Cahill, M.A. Kamm.
Prospective comparison of faecal incontinence grading systems.
[18]
Y. Maeda, D. Parés, C. Norton, C.J. Vaizey, M.A. Kamm.
Does the St. Mark’s incontinence score reflect patients’ perceptions? A review of 390 patients.
Dis Colon Rectum, 51 (2008), pp. 436-442
[19]
J.E. Ware Jr., C.D. Sherbourne.
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
Med Care, 30 (1992), pp. 473-483
[20]
T.H. Rockwood, J.M. Church, J.W. Fleshman, R.L. Kane, C. Mavrantonis, C.A.G. Thorson, et al.
Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with faecal incontinence.
Dis Colon Rectum, 43 (2000), pp. 9-16
[21]
D.L. Faltin, M. Boulvain, O. Irion, S. Bretones, C. Stan, A. Weil.
Diagnosis of anal sphincter tears by postpartum endosonography to predict fecal incontinence.
Obstet Gynecol, 95 (2000), pp. 643-647
[22]
A.H. Sultan, M.A. Kamm, I.C. Talbot, R.J. Nicholls, C.I. Bartram.
Anal endosonography for identifying external sphincter defects confirmed histologically.
Br J Surg, 81 (1994), pp. 463-465
[23]
A.F. Christensen, B. Nyhuus, M.B. Nielsen, H. Christensen.
Three-dimensional anal endosonography may improve diagnostic confidence of detecting damage to the anal sphincter complex.
Br J Radiol, 78 (2005), pp. 308-311
[24]
M. Starck, M. Bohe, L. Valentin.
Effect of vaginal delivery on endosonographic anal sphincter morphology.
Eur J Obstet Gynecol Reprod Biol, 130 (2007), pp. 193-201
[25]
D.M. Oom, R.L. West, W.R. Schouten, A.B. Steensma.
Detection of anal sphincter defects in female patients with fecal incontinence: a comparison of 3-dimensional transperineal ultrasound and 2-dimensional endoanal ultrasound.
Dis Colon Rectum, 55 (2012), pp. 646-652
[26]
A.J. Malouf, A.B. Williams, S. Halligan, C.I. Bartram, S. Dhillon, M.A. Kamm.
Prospective assessment of accuracy of endoanal MR imaging and endosonography in patients with fecal incontinence.
AJR Am J Roentgenol, 175 (2000), pp. 741-745
[27]
R.L. West, S. Dwarkasing, J.W. Briel, B.E. Hansen, S.M. Hussain, W.R. Schouten, et al.
Can three-dimensional endoanal ultrasonography detect external anal sphincter atrophy? A comparison with endoanal magnetic resonance imaging.
Int J Colorectal Dis., 20 (2005), pp. 328-333
[28]
K. Singh, W.M. Reid, L.A. Berger.
Assessment and grading of pelvic organ prolapse by use of dynamic magnetic resonance imaging.
Am J Obstet Gynecol, 185 (2001), pp. 71-77
[29]
A.E. Bharucha.
Pro: anorectal testing is useful in fecal incontinence.
Am J Gastroenterol, 101 (2006), pp. 2679-2681
[30]
F. Azpiroz, P. Enck, W.E. Whitehead.
Anorectal functional testing: review of collective experience.
Am J Gastroenterol, 97 (2002), pp. 232-240
[31]
D.C. Bartolo, J.A. Jarratt, N.W. Read.
The use of conventional electromyography to assess external sphincter neuropathy in man.
J Neurol Neurosurg Psychiatry, 46 (1983), pp. 1115-1118
[32]
D.M. Cheong, C.A. Vaccaro, V.D. Salanga, S.D. Wexner, R.C. Phillips, M.R. Hanson, et al.
Electrodiagnostic evaluation of fecal incontinence.
Muscle Nerve, 18 (1995), pp. 612-619
[33]
V. Appalaneni, R.D. Fanelli, R.N. Sharaf, M.A. Anderson, S. Banerjee, T. Ben-Menachem, et al.
ASGE Technology Committee. The role of endoscopy in patients with anorectal disorders.
Gastrointest Endosc, 72 (2010), pp. 1117-1123
[34]
J.L. Hansen, D.Z. Bliss, C. Peden-McAlpine.
Diet strategies used by women to manage fecal incontinence.
J Wound Ostomy Continence Nurs, 33 (2006), pp. 52-61
[35]
E. Croswell, D.Z. Bliss, K. Kay Savik.
Diet and eating pattern modifications used by community living adults to manage their fecal incontinence.
Wound Ostomy Continence Nurs, 37 (2010), pp. 677-682
[36]
D.Z. Bliss, K. Savik, H.J. Jung, R. Whitebird, A. Lowry, X. Sheng.
Dietary fiber supplementation for fecal incontinence: a randomized clinical trial.
Res Nurs Health, 37 (2014), pp. 367-378
[37]
Y. Ribas, A. Muñoz-Duyos.
Conservative treatment of severe defecatory urgency and fecal incontinence: minor strategies with major impact.
Tech Coloproctol, 22 (2018), pp. 673-682
[38]
P.F. Vollebregt, A.K. Elfrink, W.J. Meijerink, R.J. Felt-Bersma.
Results of long-term retrograde rectal cleansing in patients with constipation or fecal incontinence.
Tech Coloproctol, 20 (2016), pp. 633-639
[39]
T. Juul, P. Christensen.
Prospective evaluation of transanal irrigation for fecal incontinence and constipation.
Tech Coloproctol, 21 (2017), pp. 363-371
[40]
M. Dale, H. Morgan, K. Carter, J. White, G. Carolan-Rees.
Peristeen transanal irrigation system to manage bowel dysfunction: a NICE medical technology guidance.
Appl Health Econ Health Policy, 17 (2019), pp. 25-34
[41]
M.I. Omar, C.E. Alexander.
Drug treatment for faecal incontinence in adults.
Cochrane Database Syst Rev, 2013 (2013), pp. CD002116
[42]
C. Simillis, N. Lal, G. Pellino, D. Bairda, S. Nikolaoua, C. Kontovounisiosa, et al.
A systematic review and network meta-analysis comparing treatments for faecal incontinence.
Int J Surg, 66 (2019), pp. 37-47
[43]
F.L. Bach, B.Z.F. Sairally, P. Latthe.
Effect of oestrogen therapy on faecal incontinence in postmenopausal women: a systematic review.
Int Urogynecol J, 31 (2020), pp. 1289-1297
[44]
A. Arasteh, S. Mostafavi, S. Zununi Vahed, S.S. Mostafavi Montazeri.
An association between incontinence and antipsychotic drugs: a systematic review.
Biomed Pharmacother, 142 (2021), pp. 112027
[45]
S. Heymen, Y. Scarlett, K. Jones, Y. Ringel, D. Drossman, W.E. Whitehead, et al.
Randomized controlled trial shows biofeedback to be superior to alternative treatments for fecal incontinence.
Dis Colon Rectum, 52 (2009), pp. 1730-1737
[46]
G. Lacima, M. Pera, A. Amador, G. Escaramis, J.M. Piqué.
Long-term results of biofeedback treatment for faecal incontinence: a comparative study with untreated controls.
Colorectal Dis, 12 (2010), pp. 742-749
[47]
K. Maeda, T. Mimura, K. Yoshioka, M. Seki, H. Katsuno, Y. Takao, et al.
Fecal Incontinence Guideline Preparation Committee. japanese practice guidelines for fecal incontinence part 2-examination and conservative treatment for fecal incontinence—English version.
J Anus Rectum Colon, 28 (2021), pp. 67-83
[48]
L.L. Jensen, A.C. Lowry.
Biofeedback improves functional outcome after sphincteroplasty.
Dis Colon Rectum, 40 (1997), pp. 197-200
[49]
L. Ghahramani, M. Mohammadipour, R. Roshanravan, F. Hajihosseini, A. Bananzadeh, A. Izadpanah, et al.
Efficacy of biofeedback therapy before and after sphincteroplasty for fecal incontinence because of obstetric injury: a randomized controlled trial.
Iran J Med Sci, 41 (2016), pp. 126-131
[50]
K.M. Scott.
Pelvic floor rehabilitation in the treatment of fecal incontinence.
Clin Colon Rectal Surg, 27 (2014), pp. 99-105
[51]
A. Ussing, I. Dahn, U. Due, M. Sørensen, J. Petersen, T. Bandholm.
Efficacy of supervised pelvic floor muscle training and biofeedback vs attention-control treatment in adults with fecal incontinence.
Clin Gastroenterol Hepatol, 17 (2019), pp. 2253-2261
[52]
G. Hosker, J.D. Cody, C.C. Norton.
Electrical stimulation for faecal incontinence in adults.
Cochrane Database Systemat Rev, (2007), pp. 1-50
[53]
R. Vonthein, T. Heimerl, T. Schwandner, A. Ziegler.
Electrical stimulation and biofeedback for the treatment of fecal incontinence: a systematic review.
Int J Colorectal Dis, 28 (2013), pp. 1567-1577
[54]
T. Schwandner, C. Hemmelmann, T. Heimerl, W. Kierer, G. Kolbert, R. Vonthein, et al.
Tripletarget treatment versus low-frequency electrostimulation for anal incontinence.
Dtsch Arztebl Int, 108 (2011), pp. 653-660
[55]
M. Deutekom, A.C. Dobben.
Plugs for containing faecal incontinence.
Cochrane Database Syst Rev, 7 (2015), pp. CD005086
[56]
E.S. Lukacz, M.M. Segall, S.D. Wexner.
Evaluation of an anal insert device for the conservative management of fecal incontinence.
Dis Colon Rectum, 58 (2015), pp. 892-898
[57]
C.A. Leo, G.P. Thomas, J.D. Hodgkinson, J.P. Segal, Y. Maeda, J. Murphy, et al.
The Renew® anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device.
Colorectal Dis, 21 (2019), pp. 684-688
[58]
H.E. Richter, C.A. Matthews, T. Muir, M.M. Takase-Sanchez, D.S. Hale, D. Van Drie, et al.
A vaginal bowel-control system for the treatment of fecal incontinence.
Obstet Gynecol, 125 (2015), pp. 540-547
[59]
H.E. Richter, G. Dunivan, H.W. Brown, U. Andy, K.Y. Dyer, C.H. Rardin, et al.
A 12-month clinical durability of effectiveness and safety evaluation of a vaginal bowel control system for the nonsurgical treatment of fecal incontinence.
Female Pelvic Med Reconstr Surg, 25 (2019), pp. 113-119
[60]
A. Benezech, M. Bouvier, V. Vitton.
Faecal incontinence: current knowledges and perspectives.
World J Gastrointest Pathophysiol, 7 (2016), pp. 59-71
[61]
V. Pla-Martí, D. Moro-Valdezate, R. Alos-Company, A. Solana-Bueno, J.V. Roig-Vila.
The effect of surgery on quality of life in patients with faecal incontinence of obstetric origin.
Colorectal Dis, 9 (2007), pp. 90-95
[62]
B.R. Grey, R.R. Sheldon, K.J. Telford, E.S. Kiff.
Anterior anal sphincter repair can be of long term benefit: a 12-year case cohort from a single surgeon.
[63]
A.J. Malouf, C.S. Norton, A.F. Engel, R.J. Nicholls, M.A. Kamm.
Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma.
[64]
S. Maslekar, A.B. Gardiner, G.S. Duthie.
Anterior anal sphincter repair for fecal incontinence: good longterm results are possible.
J Am Coll Surg, 204 (2007), pp. 40-46
[65]
A.S. Chen, M.A. Luchtefeld, A.J. Senagore, J.M. Mackeigan, C. Hoyt.
Pudendal nerve latency. Does it predict outcome of anal sphincter repair?.
Dis Colon Rectum, 41 (1998), pp. 1005-1009
[66]
S.C. Glasgow, A.C. Lowry.
Long-term outcomes of anal sphincter repair for fecal incontinence: a systematic review.
Dis Colon Rectum, 55 (2012), pp. 482-490
[67]
A. Bravo Gutierrez, R.D. Madoff, A.C. Lowry, S.C. Parker, W.D. Buie, N.N. Baxter.
Long-term results of anterior sphincteroplasty. Long-term results of anterior sphincteroplasty.
Dis Colon Rectum, 47 (2004), pp. 727-731
[68]
M. Zutshi, T.H. Tracey, J. Bast, A. Halverson, J. Na.
Ten-year outcome after anal sphincter repair for fecal incontinence.
Dis Colon Rectum, 52 (2009), pp. 1089-1094
[69]
K. Lehto, M. Hyöty, P. Collin, H. Huhtala, P. Aitola.
Seven-year follow-up after anterior sphincter reconstruction for faecal incontinence.
Int J Colorectal Dis, 28 (2013), pp. 653-658
[70]
G. El-Gazzaz, M. Zutshi, C. Hannaway, B. Gurland, T. Hull.
Overlapping sphincter repair: does age matter?.
Dis Colon Rectum, 55 (2012), pp. 256-261
[71]
A.G. Parks, J.F. McPartlin.
Late repair of injuries of the anal sphincter.
Proc R Soc Med, 64 (1971), pp. 1187-1189
[72]
D.T. Fang, S. Nivatvongs, F.D. Vermeulen, F.N. Herman, S.M. Goldberg, D.A. Rothenberger.
Overlapping sphincteroplasty for acquired anal incontinence.
Dis Colon Rectum, 27 (1984), pp. 720-722
[73]
A.F. Engel, M.A. Kamm, A.H. Sultan, C.I. Bartram, R.J. Nicholls.
Anterior anal sphincter repair in patients with obstetric trauma.
Br J Surg, 81 (1994), pp. 1231-1234
[74]
J. García Armengol, C. Martínez Pérez, J.V. Roig Vila.
Esfinteroplastia anatómica mediante reconstrucción combinada del esfínter anal interno y externo en el tratamiento quirúrgico de la incontinencia anal.
Cir Esp, 100 (2022), pp. 580-584
[75]
C. Cerdán Santacruz, D.M. Cerdán Santacruz, L. Milla Collado, A. Ruiz de León, J. Cerdán Miguel.
Multimodal management of fecal incontinence focused on sphincteroplasty: long-term outcomes from a single center. Case series.
J Clin Med, 11 (2022), pp. 3755-3766
[76]
R.J. Fernando, A.H. Sultan, C. Kettle, R. Thakar.
Methods of repair for obstetric anal sphincter injury.
Cochrane Database Syst Rev, 12 (2013), pp. CD002866
[77]
I. Moscovitz, N.A. Rotholtz, M.K. Baig, R.H. Zhao, D.T.Y. Lam, J.J. Nogueras, et al.
Overlapping sphincteroplasty: does preservation of the scar influence immediate outcome?.
Colorectal Dis, 4 (2002), pp. 275-279
[78]
J.A. Van Koughnett, S.D. Wexner.
Current management of faecal incontinence: choosing amongst treatment options to optimize outcomes.
World J Gastroenterology, 19 (2013), pp. 9216-9230
[79]
J.W. Briel, L.M. de Boer, C.J. Hop, W.R. Schouten.
Clinical outcome of anterior overlapping external anal sphincter repair with internal anal sphincter imbrication.
Dis Colon Rectum, 41 (1998), pp. 209-214
[80]
M. Oberwalder, A. Dinnewitzer, M.K. Baig, J.J. Nogueras, E.G. Weiss, J. Efron, et al.
Do internal anal sphincter defects decrease the success rate of anal sphincter repair?.
Tech Coloproctol, 10 (2006), pp. 94-97
[81]
A.M. Leroi, M.A. Kamm, J. Weber, P. Denis, P.R. Hawley.
Internal anal sphincter repair.
Int J Colorectal Dis, 12 (1997), pp. 243-245
[82]
R. Morgan, B. Patel, J. Beynon, N.D. Carr.
Surgical management of anorectal incontinence due to internal anal sphincter deficiency.
Br J Surg, 84 (1997), pp. 226-230
[83]
A.A. Abou-Zeid.
Preliminary experience in management of fecal incontinence caused by internal anal sphincter injury.
Dis Colon Rectum, 43 (2000), pp. 198-204
[84]
P. Aitola, K.M. Hiltunen, M. Matikainen.
Functional results of anterior levatorplasty and external sphincter plication for faecal incontinence.
Ann Chir Gynaecol, 89 (2000), pp. 29-32
[85]
R. Miller, W.J. Orrom, H. Cornes, G. Duthie, D.C. Bartolo.
Anterior sphincter plication and levatorplasty in the treatment of faecal incontinence.
Br J Surg, 76 (1989), pp. 1058-1060
[86]
J.R. Hollingshead, J. Warusavitarne, C.J. Vaizey, J.M. Northover.
Outcomes following repair of traumatic cloacal deformities.
Br J Surg, 96 (2009), pp. 1082-1085
[87]
D.F. Altomare, M. Rinaldi, V. Bucaria, F. Marino, P. Lobascio, P.L. Sallustio.
Overlapping sphincteroplasty and modified lotus petal flap for delayed repair of traumatic cloaca.
Tech Coloproctol, 11 (2007), pp. 268-270
[88]
C. Cerdán Santacruz, O. Cano Valderrama, J. Cerdán Miguel.
Traumatic deficient perineum: surgical management and outcome from a single center.
Intern Urogynecology J, 33 (2022), pp. 651-658
[89]
G. Pinedo, C.J.I. Vaizey, R.J. Nicholls, R. Roach, S. Halligan, M.A. Kamm.
Results of repeat anal sphincter repair.
[90]
C.J. Vaizey, C. Norton, M.J. Thornton, R.J. Nicholls, M.A. Kamm.
Long-term results of repeat anterior anal sphincter repair.
Dis Colon Rectum, 47 (2004), pp. 858-863
[91]
P. Giordano, A. Renzi, J. Efron, P. Gervaz, E.G. Weiss, J.J. Nogueras, et al.
Previous sphincter repair does not affect the outcome of repeat repair.
Dis Colon Rectum, 45 (2002), pp. 635-640
[92]
H. Hasegawa, K. Yoshioka, M.R. Keighley.
Randomized trial of fecal diversion for sphincter repair.
Dis Colon Rectum, 43 (2000), pp. 961-964
[93]
R. Mahony, M. Behan, C. O’Herlihy, P.R. O’Connell.
Randomized, clinical trial of bowel confinement vs. laxative use after primary repair of a third-degree obstetric anal sphincter tear.
Dis Colon Rectum, 47 (2004), pp. 12-17
[94]
A. Nessim, S.D. Wexner, F. Agachan, O. Alabaz, E.G. Weiss, J.J. Nogueras, et al.
Is bowel confinement necessary after anorectal reconstructive surgery? A prospective, randomized, surgeon-blinded trial.
Dis Colon Rectum, 42 (1999), pp. 16-23
[95]
W.D. Buie, A.C. Lowry, D.A. Rothenberger, R.D. Madoff.
Clinical rather than laboratory assessment predicts continence after anterior sphincteroplasty.
Dis Colon Rectum, 44 (2001), pp. 1255-1260
[96]
V. Pla-Martí, J. Martín-Arévalo, R. Martí-Fernández, D. Moro-Valdezate, S. García-Botello, A. Espí-Macías, et al.
Long-term evolution of continence and quality of life after sphincteroplasty for obstetric fecal incontinence.
Ann Coloproctol, 38 (2020), pp. 13-19
[97]
C.J. Young, M.N. Mathur, A.A. Eyers, M.J. Solomon.
Successful overlapping anal sphincter repair: relationship to patient age, neuropathy, and colostomy formation.
Dis Colon Rectum, 41 (1998), pp. 344-349
[98]
M. Pinho, J. Ortiz, M. Oya, B. Panagamuwa, J. Asperer, M.R. Keighley.
Total pelvic floor repair for the treatment of neuropathic fecal incontinence.
Am J Surg, 63 (1992), pp. 340-343
[99]
G.G. Browning, M.M. Henry, R.W. Motson.
Combined sphincter repair and postanal repair for the treatment of complicated injuries to the anal sphincters.
Ann R Coll Surg Engl, 70 (1988), pp. 324-328
[100]
M.R. Keighley.
Postanal repair for faecal incontinence.
J R Soc Med, 77 (1984), pp. 285-288
[101]
G.G. Browning, A.G. Parks.
Postanal repair for neuropathic faecal incontinence: correlation of clinical result and anal canal pressures.
Br J Surg, 70 (1983), pp. 101-104
[102]
S. Korsgen, K.I. Deen, M.R. Keighley.
Long-term results of total pelvic floor repair for postobstetric fecal incontinence.
Dis Colon Rectum, 40 (1997), pp. 835-839
[103]
C.G. Baeten, J. Konsten, F. Spaans, R. Visser, A.M. Habets, I.M. Bourgeois, et al.
Dynamic graciloplasty for treatment of faecal incontinence.
Lancet, 338 (1991), pp. 1163-1165
[104]
A.E. Chapman, B. Geerdes, P. Hewett, J. Young, T. Eyers, G. Kiroff, et al.
Systematic review of dynamic graciloplasty in the treatment of faecal incontinence.
[105]
C.G. Baeten, H.R. Bailey, A. Bakka, P. Belliveau, E. Berg, W.D. Buie, et al.
Safety and efficacy of dynamic graciloplasty for fecal incontinence: report of a prospective, multicenter trial. Dynamic Graciloplasty Therapy Study Group.
Dis Colon Rectum, 43 (2000), pp. 743-751
[106]
M.J. Thornton, M.L. Kennedy, D.Z. Lubowski, D.W. King.
Long-term follow-up of dynamic graciloplasty for faecal incontinence.
Colorectal Dis, 6 (2004), pp. 470-476
[107]
K.E. Matzel, R.D. Madoff, L.J. LaFontaine, C.G. Baeten, W.D. Buie, J. Christiansen, et al.
Dynamic Graciloplasty Therapy Study Group. Complications of dynamic graciloplasty: incidence, management, and impact on outcome.
Dis Colon Rectum, 44 (2001), pp. 1427-1435
[108]
J.M. Devesa, J.M. Madrid, B.R. Gallego, E. Vicente, J. Nuño, J.M. Enríquez.
Bilateral gluteoplasty for fecal incontinence.
Dis Colon Rectum., 40 (1997), pp. 883-888
[109]
C.S. Hultman, M.R. Zenn, T. Agarwal, C.C. Baker.
Restoration of fecal continence after functional gluteoplasty: long-term results, technical refinements, and donor-site morbidity.
Ann Plast Surg, 56 (2006), pp. 65-70
[110]
H.B. Goldman, J.C. Lloyd, K.L. Noblett, M.P. Carey, J.C. Castaño Botero, J.B. Gajewski, et al.
International Continence Society best practice statement for use of sacral neuromodulation.
Neurourol Urodyn, 37 (2018), pp. 1823-1848
[111]
A. Gupta, C. Kinman, D.T.G. Hobson, K.V. Meriwether, J.T. Gaskins, M.N. Uddin, et al.
The impact of fluoroscopy during percutaneous nerve evaluation on subsequent implantation of a sacral neuromodulator among women with pelvic floor disorders: a randomized, noninferiority trial.
Neuromodulation, 23 (2020), pp. 1164-1171
[112]
J. Shakuri-Rad, A. Cicic, J. Thompson.
Prospective randomized study evaluating ultrasound versus fluoroscopy guided sacral InterStim® lead placement: a pilot study.
Neurourol Urodyn, 37 (2018), pp. 1737-1743
[113]
A. Navarro, A. Muñoz, A. Arroyo, J. Castillo, M. Ortega.
Guía de estandarización para neuromodulación de las raíces sacras en coloproctología.
AT PN Medtronic Ibérica, (2018),
[114]
K.E. Matzel, E. Chartier-Kastler, C.H. Knowles, P.A. Lehur, A. Muñoz-Duyos, C. Ratto, et al.
Sacral neuromodulation: standardized electrode placement technique.
Neuromodulation, 20 (2017), pp. 816-824
[115]
K. Jottard, S. Van den Broeck, N. Komen, L. Bruyninx, S. De Wachter.
Treatment of fecal incontinence with a rechargeable sacral neuromodulation system: efficacy, clinical outcome, and ease of use-six-month follow-up.
Neuromodulation, 24 (2021), pp. 1284-1288
[116]
L. Lundby, A. Møller, S. Buntzen, K. Krogh, K. Vang, A. Gjedde, et al.
Relief of fecal incontinence by sacral nerve stimulation linked to focal brain activation.
Dis Colon Rectum, 54 (2011), pp. 318-323
[117]
G.E. Gmel, P.F. Vollebregt, M.E.G. Thijssen, R. Santos Escapa, E. McAlees, D. Mugan, et al.
Electrophysiological responses in the human S3 nerve during sacral neuromodulation for fecal incontinence.
Front Neurosci, 15 (2021), pp. 712168
[118]
J.J. Tjandra, M.K. Chan, C.H. Yeh, C. Murray-Green.
Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study.
Dis Colon Rectum, 51 (2008), pp. 494-502
[119]
A. Hotouras, J. Murphy, N.N. Thin, M. Allison, E. Horrocks, N.S. Williams, et al.
Outcome of sacral nerve stimulation for fecal incontinence in patients refractory to percutaneous tibial nerve stimulation.
Dis Colon Rectum, 56 (2013), pp. 915-920
[120]
A. Muñoz-Duyos, L. Lagares-Tena, Y. Ribas, J.C. Baanante, A. Navarro-Luna.
Critical appraisal of international guidelines for the management of fecal incontinence in adults: is it possible to define what to do in different clinical scenarios?.
Tech Coloproctol, 26 (2022), pp. 1-17
[121]
D.F. Altomare, S. Giuratrabocchetta, C.H. Knowles, A. Muñoz Duyos, J. Robert-Yap, K.E. Matzel, et al.
Long-term outcomes of sacral nerve stimulation for faecal incontinence.
Br J Surg, 102 (2015), pp. 407-415
[122]
Y. Maeda, P.R. O’Connell, P.A. Lehur, K.E. Matzel, S. Laurberg.
European SNS Bowel Study Group. Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement.
Colorectal Dis, 17 (2015), pp. O74-O87
[123]
N.N. Thin, E.J. Horrocks, A. Hotouras, S. Palit, M.A. Thaha, C.L. Chan, et al.
Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence.
Br J Surg, 100 (2013), pp. 1430-1447
[124]
T. Hull, C. Giese, S.D. Wexner, A. Mellgren, G. Devroede, R.D. Madoff, et al.
Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence.
Dis Colon Rectum, 56 (2013), pp. 234-245
[125]
P.T. Janssen, S.Z. Kuiper, L.P. Stassen, N.D. Bouvy, S.O. Breukink, J. Melenhorst.
Fecal incontinence treated by sacral neuromodulation: Long-term follow-up of 325 patients.
Surgery, 161 (2017), pp. 1040-1048
[126]
B. Widmann, C. Galata, R. Warschkow, U. Beutner, Ö. Ögredici, F.H. Hetzer, et al.
Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study.
J Neurogastroenterol Motil, 25 (2019), pp. 159-170
[127]
Y. Maeda, K. Matzel, L. Lundby, S. Buntzen, S. Laurberg.
Postoperative issues of sacral nerve stimulation for fecal incontinence and constipation: a systematic literature review and treatment guideline.
Dis Colon Rectum, 54 (2011), pp. 1443-1460
[128]
C. Ratto, F. Litta, A. Parello, L. Donisi, V. De Simone, G. Zaccone.
Sacral nerve stimulation in faecal incontinence associated with an anal sphincter lesion: a systematic review.
Colorectal Dis, 14 (2012), pp. e297-304
[129]
M.B. Rydningen, T. Dehli, T. Wilsgaard, R.O. Lindsetmo, M. Kumle, M. Stedenfeldt, et al.
Sacral neuromodulation for faecal incontinence following obstetric sphincter injury — outcome of percutaneous nerve evaluation.
Colorectal Dis, 19 (2017), pp. 274-282
[130]
M.E. Jarrett, K.E. Matzel, J. Christiansen, C.G. Baeten, H. Rosen, B. Bittorf, et al.
Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse.
Br J Surg, 92 (2005), pp. 734-739
[131]
B. Holzer, H.R. Rosen, G. Novi, C. Ausch, N. Hölbling, R. Schiessel.
Sacral nerve stimulation for neurogenic faecal incontinence.
Br J Surg., 94 (2007), pp. 749-753
[132]
L. Ramage, S. Qiu, C. Kontovounisios, P. Tekkis, S. Rasheed, E. Tan.
A systematic review of sacral nerve stimulation for low anterior resection syndrome.
Colorectal Dis, 17 (2015), pp. 762-771
[133]
S.M. Eftaiha, B. Balachandran, S.J. Marecik, A. Mellgren, J. Nordenstam, G. Melich, et al.
Sacral nerve stimulation can be an effective treatment for low anterior resection syndrome.
Colorectal Dis, 19 (2017), pp. 927-933
[134]
E. Ram, R. Meyer, D. Carter, M. Gutman, D. Rosin, N. Horesh.
The efficacy of sacral neuromodulation in the treatment of low anterior resection syndrome: a systematic review and meta-analysis.
Tech Coloproctol, 24 (2020), pp. 803-815
[135]
J. Fassov, L. Lundby, S. Laurberg, S. Buntzen, K. Krogh.
Three-year follow-up of sacral nerve stimulation for patients with diarrhoea-predominant and mixed irritable bowel syndrome.
Colorectal Dis, 19 (2017), pp. 188-193
[136]
L. Lagares-Tena, L. Millán-Paredes, L. Lázaro-García, A. Navarro-Luna, S. Delgado-Rivilla, A. Muñoz-Duyos.
Sacral neuromodulation in patients with congenital faecal incontinence. Special issues and review of the literature.
Tech Coloproctol, 22 (2018), pp. 89-95
[137]
L. Lagares-Tena, C. Corbella-Sala, A. Navarro-Luna, A. Muñoz-Duyos.
Sacral neuromodulation in a patient with faecal incontinence and unknown sacral partial agenesis.
Colorectal Dis, 19 (2017), pp. 502-504
[138]
J. Castillo, L. Cristóbal, J. Alonso, R. Martín, D. Suárez, M.A. Martínez, et al.
Sacral nerve stimulation lead implantation in partial sacral agenesis using intra-operative computerized tomography.
Colorectal Dis, 18 (2016), pp. O330-O333
[139]
A. Shafik, I. Ahmed, O. El-Sibai, R.M. Mostafa.
Percutaneous peripheral neuromodulation in the treatment of fecal incontinence.
Eur Surg Res, 35 (2003), pp. 103-107
[140]
A.T. George, K. Kalmar, S. Sala, K. Kopanakis, A. Panarese, T.C. Dudding, et al.
Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence.
Br J Surg, 100 (2013), pp. 330-338
[141]
M. Eleouet, L. Siproudhis, N. Guillou, J. Le Couedic, G. Bouguen, J.F. Bretagne.
Chronic posterior tibial nerve transcutaneous electrical nerve stimulation (TENS) to treat fecal incontinence (FI).
Int J Colorectal Dis, 25 (2010), pp. 1127-1132
[142]
V. Vitton, H. Damon, S. Roman, F. Mion.
Transcutaneous electrical posterior tibial nerve stimulation for faecal incontinence: effects on symptoms and quality of life.
Int J Colorectal Dis, 25 (2010), pp. 1017-1020
[143]
G.P. Thomas, T.C. Dudding, R.J. Nicholls, C.J. Vaizey.
Bilateral transcutaneous posterior tibial nerve stimulation for the treatment of fecal incontinence.
Dis Colon Rectum, 56 (2013), pp. 1075-1079
[144]
G. Dedemadi, S. Takano.
Efficacy of bilateral transcutaneous posterior tibial nerve stimulation for fecal incontinence.
Perm J, 22 (2018), pp. 17-231
[145]
A.T. George, R.K. Maitra, C. Maxwell-Armstrong.
Posterior tibial nerve stimulation for fecal incontinence: where are we?.
World J Gastroenterol, 19 (2013), pp. 9139-9145
[146]
F.G. Marinello, L.M. Jiménez, E. Talavera, D. Fraccalvieri, P. Alberti, F. Ostiz, et al.
Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial.
Br J Surg, 108 (2021), pp. 380-387
[147]
C.H. Knowles, E.J. Horrocks, S.A. Bremmer, N. Stevens, C. Norton, P.R. OConnell, et al.
Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmàtic, parallel-group, randomised controlled trial.
Lancet, 366 (2015), pp. 1640-1648
[148]
C. Similis, N. Lal, S. Qiu, C. Kontovounisios, S. Rasheed, E. Tan, et al.
Sacral nerve stimulation versus percutaneous tibial nerve stimulation for faecal incontinence: a systematic review and meta-analysis.
Int J Colorectal Dis, 33 (2018), pp. 645-648
[149]
N. Hounsome, C. Roukas.
Cost-effectiveness of sacral nerve stimulation and percutaneous tibial nerve stimulation for faecal incontinence.
Therap Adv Gastroenterol, 11 (2018),
[150]
F. De la Portilla, R. Rada, J. Vega, C.A. Gonzalez, N. Cisneros, V.H. Maldonado.
Evaluation of the use of posterior tibial nerve stimulation for the treatment of fecal incontinence: preliminary results of a prospective study.
Dis Colon Rectum, 52 (2009), pp. 1427-1433
[151]
A. Hotouras, J. Murphy, U. Walsh, M. Allison, A. Curry, N.S. Williams, et al.
Outcome of percutaneous tibial nerve stimulation (NMPTP) for fecal incontinence: a prospective cohort study.
Ann Surg, 259 (2014), pp. 939-943
[152]
P.A. Lehur, J.V. Roig, M. Duinslaeger.
Artificial anal sphincter. Prospective clinical and manometric evaluation.
Dis Colon Rectum, 43 (2000), pp. 1100-1106
[153]
M.D. Ruiz-Carmona, R. Alós-Company, J.V. Roig-Vila, A. Solana-Bueno, V. Pla-Martí.
Long-term results of artificial bowel sphincter for the treatment of severe faecal incontinence. Are they what we hoped for?.
Colorectal Dis, 11 (2009), pp. 831-837
[154]
P.A. Lehur, D. Christoforidis, G. Meurette.
Artificial sphincters to treat severe fecal incontinence: currently in a deadlock.
Dis Colon Rectum, 63 (2020), pp. 1017-1019
[155]
G. Dodi, J. Jongen, F. de la Portilla, M. Raval, D.F. Altomare, P.A. Lehur.
An open-label, noncomparative, multicenter study to evaluate efficacy and safety of NASHA/Dx gel as a bulking agent for the treatment of fecal incontinence.
Gastroenterol Res Pract, 2010 (2010), pp. 467136
[156]
J. Danielson, U. Karlbom, T. Wester, W. Graf.
Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents.
Tech Coloproctol, 17 (2013), pp. 389-395
[157]
N.F. Watson, A. Koshy, P.M. Sagar.
Anal bulking agents for faecal incontinence.
Colorectal Dis, 14 (2012), pp. 29-33
[158]
K.D. Hong, J.S. Kim, W.B. Ji, J.W. Um.
Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta-analysis.
Tech Coloproctol, 21 (2017), pp. 203-210
[159]
W.R. De Ligny, M.H. Kerkhof, A.M. Ruiz-Zapata.
Regenerative medicine as a therapeutic option for faecal incontinence: a systematic review of preclinical and clinical studies.
Am J Obstet Gynecol, 220 (2019), pp. 142-154
[160]
A. Frudinger, J. Pfeifer, J. Paede, V. Kolovetsiou-Kreiner, R. Marksteiner, S. Halligan.
Autologous skeletal-muscle-derived cell injection for anal incontinence due to obstetric trauma: a 5-year follow-up of an initial study of 10 patients.
Colorectal Dis, 17 (2015), pp. 794-801
[161]
A. Sarveazad, G.L. Newstead, R. Mirzaei, M.T. Joghataei, M. Bakhtiari, A. Babahajian, et al.
A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double-blind clinical trial.
Stem Cell Research Ther, 8 (2017), pp. 40-50
[162]
M. Frascio, F. Mandolfino, M. Imperatore, C. Stabilini, R. Fornaro, E. Gianetta, et al.
The SECCA procedure for faecal incontinence: a review.
Dis Colorrectal, 16 (2014), pp. 167-172
[163]
O. Vergara-Fernández, J.A. Arciniega-Hernández, M. Trejo-Avila.
Long-term outcomes of radiofrequency treatment for fecal incontinence: are the results maintainable?.
Int J Colorrectal Dis, 35 (2020), pp. 173-176
[164]
A.P. Visscher, T.J. Lam, M.M. Meurs-Szojda, R.J.F. Felt-Bersma.
Temperature-controlled delivery of radiofrequency energy in fecal incontinence: a randomized sham-controlled clinical trial.
Dis Colon Rectum, 60 (2017), pp. 860-865
[165]
P. Rosenblatt, J. Schumacher, V. Lucente, S. McNevin, J. Rafferty, A. Mellgren.
A preliminary evaluation of the TOPAS system for the treatment of fecal incontinence in women.
Female Pelvic Med Reconstr Surg, 20 (2014), pp. 155-162
[166]
A. Mellgren, M. Zutshi, V.R. Lucente, P. Culligan, D.E. Fenner.
TOPAS Study Group. A posterior anal sling for fecal incontinence: results of a 152-patient prospective multicenter study.
Am J Obstet Gynecol, 214 (2016),
[167]
W.D. Winkelman, V.O. Demtchouk, L.G. Brecher, A.P. Erlinger, A.M. Modest, P.L. Rosenblatt.
Long-term fecal incontinence, recurrence, satisfaction, and regret after the transobturator postanal sling procedure.
Female Pelvic Med Reconstr Surg, 27 (2019), pp. 244-248
[168]
A.S. Patel, A. Saratzis, R. Arasaradnam, C. Harmston.
Use of antegrade continence enema for the treatment of fecal incontinence and functional constipation in adults: a systematic review.
Dis Colon Rectum, 58 (2015), pp. 999-1013
[169]
D.S. Chan, R.J. Delicata.
Meta-analysis of antegrade continence enema in adults with fecal incontinence and constipation.
Br J Surg, 103 (2016), pp. 322-327
[170]
M.S. Kelly.
Malone antegrade continence enemas vs. cecostomy vs. transanal irrigation—what is new and how do we counsel our patients?.
Curr Urol Rep, 20 (2019), pp. 41-48
[171]
J.T. Franco, A.M. Agulhon, F.C. Viani, R.G. Viebig.
Systemic acupuncture in patients with faecal incontinence.
Complement Ther Clin Pract, 24 (2016), pp. 162-166
[172]
M. Scaglia, G. Delaini, I. Destefano, L. Hultén.
Fecal incontinence treated with acupuncture—a pilot study.
Auton Neurosci, 145 (2009), pp. 89-92
[173]
H.S. Goldsmith, A. Chandra.
Pyloric valve transposition as substitute for a colostomy in humans: a preliminary report.
Am J Surg, 202 (2011), pp. 409-416
[174]
A. Chandra, A. Kumar, M. Noushif, V. Gupta, D. Singh, M. Kumar, et al.
Perineal antropylorus transposition for end-stage fecal incontinence in humans: initial outcomes.
Dis Colon Rectum, 56 (2013), pp. 360-366
[175]
B. Mishra, A. Chandra, S. Gejje, M. Noushif, D.N. Upadhyay, N. Mishra.
Free antropyloric valve flap for end-stage fecal incontinence as a substitute to permanent colostomy.
J Reconstr Microsurg, 32 (2016), pp. 215-221
[176]
C. Norton, J. Burch, M.A. Kamm.
Patients’ views of a colostomy for fecal incontinence.
Dis Colon Rectum, 48 (2005), pp. 1062-1069
Copyright © 2023. AEC
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos